What's New on the FDA Drugs Site
September 8, 2017
- CDER Statement: FDA warns Meridian Medical Technologies about CGMP violations associated with the manufacture of EpiPen
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Ciprofloxacin Hydrochloride Tablets (New - Discontinuation)
- Methazolamide Tablets (New - Discontinuation)
- Ranitidine Tablets (New - Discontinuation)
- Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present (updated)
- Priority Therapeutic Areas for Development (updated)
- Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access (updated)
No hay comentarios:
Publicar un comentario